ESC Premium Access

Discussion

Topic: Risk Factors and Prevention
Organised by PACE-CME, supported with an educational grant provided by Amgen, Draupnir Bio ApS, Sanofi-Regeneron & The Medicines Company

Congress Session

About the speakers

Professor John Chapman

Medical Faculty, Sorbonne University, Pitie-Salpetriere University hospital, Paris (France)
15 presentations
0 follower

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

4 more presentations in this session

Introduction

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Insights and lessons from the ODYSSEY outcomes trial: which patients benefit most?

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Extending the evidence: what did the FOURIER trial learns us on managing high risk patients?

Speaker: Professor M. Sabatine (Boston, US)

Thumbnail

Targeting PCSK9: expanding knowledge and targeting new frontiers

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

Access the full session

PCSK9i, changing practice in cardiology: the emerging story

Speakers: Professor J. Chapman, Professor J. Kastelein, Professor J. Chapman, Professor P. Steg, Professor M. Sabatine...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk